3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Nasopharyngeal Carcinoma
19
Triple Negative Breast Neoplasms
11
Breast Neoplasms
10
Carcinoma, Non-Small-Cell Lung
7
Head and Neck Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Neoplasms
5
Colorectal Neoplasms
5
Advanced Solid Tumor
5
Uterine Cervical Neoplasms
4
Stomach Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Carcinoma, Transitional Cell
4
Carcinoma, Renal Cell
4
Solid Tumor
3
Small Cell Lung Carcinoma
3
Recurrence
3
Rectal Neoplasms
3
Nasopharyngeal Neoplasms
3
Turcot syndrome
2
Sarcoma
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasm Metastasis
2
Microsatellite Stable Metastatic Colorectal Cancer
2
Locally Advanced Rectal Cancer
2
Liposarcoma
2
Laryngeal Neoplasms
2
Gestational Trophoblastic Disease
2
Esophageal Neoplasms
2
Interventions
toripalimab
2
Oxaliplatin
2
Capecitabine
2
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Early Low Rectal Cancer
×
toripalimab
×
Clear all
NCT05555888
2025-01-15
TORCH-E
Fudan University
Phase 2
Recruiting
34 enrolled
NCT06462053
2024-06-17
TORCH-E2
Fudan University
Phase 2
Recruiting
134 enrolled